Pete is the Senior Director of our Scientific Advisory Services team. His expertise in toxicology, pharmacology, pharmacokinetics, and pharmacodynamics helps guide our clients’ nonclinical development and advise them on how to strengthen and/or accelerate nonclinical programs. Dr. Gaskin specializes in several therapeutic areas, including cancer, inflammation, neurology, and cardiovascular and metabolic diseases.
Pete has over 25 years of life sciences experience and almost 20 years of experiences with various pharmaceutical companies, including PPD Consulting, Aptuit, Quintiles, and Inveresk Research. During this time, he managed early development programs to proof-of-concept, led nonclinical programs to market, and developed biologics, proteins/peptides, and small molecules.
Pete received his PhD in toxicology and metabolism from the University of Nottingham and his Bachelor’s degree in biochemistry from the University of Surrey, UK. He is currently a member of the British and European Societies of Toxicology, the American College of Toxicology, and TOPRA (The Organisation for Professionals in Regulatory Affairs).